Idelalisib and Elacestrant: Interaction Details

Brand names
Idelalisib
Zydelig
Elacestrant
Orserdu
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Idelalisib With Elacestrant

What can happen when they are taken together (rated Major)

Increased elacestrant exposure and an increased risk of elacestrant-related adverse effects

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Strong should not be used together with elacestrant. Because elacestrant is a CYP3A4 , giving it with a strong CYP3A4 raises elacestrant exposure, and this may heighten the risk of adverse reactions to elacestrant. In a dedicated interaction study, administering elacestrant at a dose of 172 mg once daily alongside itraconazole produced a 4.4-fold rise in elacestrant and a 5.3-fold rise in .1

The Idelalisib and Elacestrant Interaction, Explained

Idelalisib can raise the amount of elacestrant in your body. Idelalisib (Zydelig) blocks , a liver enzyme that helps clear elacestrant (Orserdu). With less clearing, more elacestrant stays in your blood, which can mean more side effects such as nausea, tiredness, or changes in cholesterol or liver tests.

The data behind this comes mostly from a study with a similar strong blocker (itraconazole), where elacestrant levels rose more than 5-fold. So this is a predicted interaction for idelalisib, but it is taken seriously. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor, who can review your options and decide how best to manage this for you.

Mechanism: Idelalisib is a strong ; elacestrant is a CYP3A4 . of its and intestinal increases elacestrant exposure (PK interaction, direction: increased exposure and effect).

  • Magnitude: With itraconazole (strong CYP3A4 inhibitor), elacestrant rose 4.4-fold and 5.3-fold (172 mg daily). Idelalisib data are extrapolated, so evidence for this pair is theoretical.
  • Onset: Unspecified.
  • Severity: Major.
  • Management: Avoid per labeling. If unavoidable, individualize the elacestrant dose with the care team and monitor closely for elacestrant adverse reactions (e.g., nausea, dyslipidemia, hepatic enzyme elevations, musculoskeletal pain).

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Idelalisib and Elacestrant Interact

The likely mechanism

of -mediated of elacestrant

In short: Idelalisib slows CYP3A4, an enzyme that breaks down elacestrant, so elacestrant can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Idelalisib and Elacestrant Interaction

The documented advice is to avoid using these two medicines together when possible, because idelalisib can raise elacestrant levels.

  • Your care team may look for an alternative, or may adjust and individualize the dose and monitor you more closely if both are needed.
  • Keep taking your medicines exactly as prescribed until you speak with your prescriber or pharmacist.
  • Tell them about all medicines, supplements, and grapefruit products you use.
  • Report new or worsening side effects, such as ongoing nausea, unusual tiredness, or other symptoms that concern you.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Idelalisib or Elacestrant need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: ORSERDU oral tablets, elacestrant oral tablets

    An interaction study found that when elacestrant 172 mg once daily was given together with itraconazole (a strong ), the of elacestrant rose 4.4-fold and its rose 5.3-fold.1

Idelalisib and Elacestrant: Common Questions

How serious is the Idelalisib and Elacestrant interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Idelalisib and Elacestrant interaction managed?

The documented advice is to avoid using these two medicines together when possible, because idelalisib can raise elacestrant levels. Your care team may look for an alternative, or may adjust and individualize the dose and monitor you more closely if both are needed. Keep taking your medicines exactly as prescribed until you speak with your prescriber or pharmacist. Tell them about all medicines, s… Management is individual — always follow your own care team's guidance.

Does taking Idelalisib and Elacestrant at different times of day help?

No. Taking them at different times of day does not prevent this one. Idelalisib slows , an enzyme that breaks down elacestrant, so elacestrant can build up in the body. That change lasts while idelalisib is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Idelalisib and Elacestrant Interaction

Ask in your own words about taking Idelalisib and Elacestrant together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: ORSERDU(TM) oral tablets, elacestrant oral tablets. Stemline Therapeutics (per FDA), New York, NY, 2023. DailyMed
Was this write-up helpful?

Other Serious Interactions of Idelalisib and Elacestrant

Also serious with Idelalisib

Also serious with Elacestrant

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Idelalisib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.